Australia's Therapeutic Goods Administration (TGA) has formally cleared the oral version of the Wegovy weight-loss pill for use in the country, with retail availability expected by Christmas.
The regulatory clearance introduces the popular weight-loss medication in a pill format to the Australian market, offering an alternative to existing injection-based treatments. Health authorities and consumers anticipate the product going on sale ahead of the upcoming holiday season.
The decision marks a significant milestone for local access to advanced anti-obesity treatments, broadening choices for patients and healthcare providers managing weight-loss therapies across Australia.
